Rankings
▼
Calendar
TLSI FY 2022 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
TLSI
TriSalus Life Sciences, Inc.
$175M
FY 2022 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$12M
+47.6% YoY
Gross Profit
$10M
81.8% margin
Operating Income
-$36M
-293.9% margin
Net Income
-$47M
-380.6% margin
EPS (Diluted)
$-1.59
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$33M
Stock-Based Comp.
$368,000
Balance Sheet
Total Assets
$22M
Total Liabilities
$34M
Stockholders' Equity
-$12M
Cash & Equivalents
$9M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$12M
$8M
+47.6%
Gross Profit
$10M
$7M
+40.7%
Operating Income
-$36M
-$24M
-51.6%
Net Income
-$47M
-$29M
-63.6%
← Q4 2021
All Quarters
Q1 2022 →